as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High
2.92%
Downside
2.48%
Upside
52 Week's Low
52 Week's High
37.42%
Downside
64.11%
Upside
Check Syndax Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
-3.1043
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-123.32
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-339.0M
Revenue (TTM)
77.9M
Profit Margin
0.00%
Return On Equity TTM
-113.22%
Track how Syndax Pharmaceuticals P/E has moved over time to understand its valuation trends.
Syndax Pharmaceuticals in the last 5 years
Lowest (-12.15x)
March 31, 2021
Today (-123.32x)
November 1, 2025
Industry (-0.81x)
November 1, 2025
Highest (104.05x)
June 30, 2022
Today’s Price to Earnings Ratio: -123.32x
Compare market cap, revenue, PE, and other key metrics of Syndax Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | -21.31% | -123.32 | 0.00% | |
| BUY | $40.4B | 475.59% | -16.34 | -264.83% | |
| BUY | $59.4B | 270.85% | -505.15 | -12.96% | |
| BUY | $107.7B | 104.25% | 29.84 | 31.86% | |
| BUY | $68.7B | 19.91% | 15.67 | 32.13% |
The Syndax Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Syndax Pharmaceuticals investment value today
Current value as on today
₹77,876
Returns
Returns from Syndax Pharmaceuticals Stock
Dollar Returns*
₹5,642 (+5.64%)
Based on 19 analysts
89.47%
Buy
10.53%
Hold
0.00%
Sell
Based on 19 analysts, 89.47% of analysts recommend a 'BUY' rating for Syndax Pharmaceuticals. Average target price of $38.31
Get share price movements and forecasts by analysts on Syndax Pharmaceuticals.
What analysts predicted
64.21%UPSIDE
Target Price
$38.31
Current Price
$13.71
Analyzed by
19 Analysts
Target
$38.31
Syndax Pharmaceuticals target price $38.31, a slight upside of 64.21% compared to current price of $13.71. According to 19 analysts rating.
Search interest for Syndax Pharmaceuticals Stock has increased by 251% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:251% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1009.8% return, outperforming this stock by 1051.9%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 184.3% return, outperforming this stock by 213.8%
Price Dip
![]()
In the last 1 month, SNDX stock has moved down by -14.6%
| Organisation | Syndax Pharmaceuticals |
| Headquarters | 730 Third Avenue, New York, NY, United States, 10017 |
| Industry | Health Technology |
| CEO | Mr. Michael A. Metzger M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Michael Downes Ph.D. | Co-Founder |
Sharon Klahre | Vice President of Investor Relations & Communications |
Mr. Keith Alan Goldan CPA | CFO, Treasurer & Chief Accounting Officer |
Mr. Luke J. Albrecht J.D. | Senior VP, General Counsel & Secretary |
Mr. Steven Closter | Chief Commercial Officer |
Dr. Ronald M. Evans Ph.D. | Co-Founder, Advisor and Chair of Scientific Advisory Board |
Mr. Michael A. Metzger M.B.A. | CEO & Director |
Dr. Peter Ordentlich B.Sc., Ph.D. | Co-Founder & Chief Scientific Officer |
Dr. Richard A. Heyman Ph.D. | Co-Founder |
Mr. Kevin McManus | Chief People Officer |
Syndax Pharmaceuticals share price today is $13.71 as on at the close of the market. Syndax Pharmaceuticals share today touched a day high of $14.05 and a low of $13.31.
Syndax Pharmaceuticals share touched a 52 week high of $22.5 on and a 52 week low of $8.58 on . Syndax Pharmaceuticals stock price today i.e. is closed at $13.71,which is 39.07% down from its 52 week high and 59.79% up from its 52 week low.
Syndax Pharmaceuticals market capitalisation is $0.00T as on .
Indian investors can start investing in Syndax Pharmaceuticals (SNDX) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.65 in Syndax Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Syndax Pharmaceuticals share’s latest price of $13.71 as on November 1, 2025 at 1:29 am IST, you will get 0.7294 shares of Syndax Pharmaceuticals. Learn more about
fractional shares .
Syndax Pharmaceuticals stock has given -21.31% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?